Registro:

Referencias:

• Alnemri, E.S., Maksymowych, A.B., Robertson, N.M., Litwack, G., Overexpression and characterization of the human mineralocorticoid receptor (1991) J Biol Chem, 266, pp. 3925-3936
• Benhamou, B., Garcia, T., Lerouge, T., Vergezac, A., Gofflo, D., Bigogne, C., Chambon, P., Gronemeyer, H., A single amino acid that determines the sensitivity of progesterone receptors (1992) Science, 255, pp. 206-209
• Binart, N., Lombes, M., Rafestin-Oblin, M.E., Baulieu, E.E., Characterization of human mineralocorticoid receptor expressed in the baculovirus system (1991) Proc Natl Acad Sci USA, 88, pp. 10681-10685
• Brachet-Cota, A.L., Burton, G., An improved preparation of 11,19-oxidopregn-4-ene-3,20-dione and 6,19-oxidopregn-4-ene-3,11,20-trione (1990) Z Naturforsch Teil [B], 45, pp. 711-715
• Burton, G., Galigniana, M.D., De Lavallaz, S., Brachet-Cota, A.L., Sproviero, E.M., Ghini, A.A., Lantos, C.P., Damasco, M.C., Sodium-retaining activity of some natural and synthetic 21-deoxysteroids (1995) Mol Pharmacol, 47, pp. 535-543
• Colby, H., Kitay, J., Sex and substrate effects on hepatic corticosteroid metabolism in rat (1972) Endocrinology, 90, pp. 473-478
• Czar, M.J., Galigniana, M.D., Silverstein, A.M., Pratt, W.B., Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from cytoplasm to the nucleus (1997) Biochemistry, 36, pp. 7776-7785
• Duax, W., Cody, V., Griffin, J., Rohrer, D., Weeks, C., Molecular conformation and protein binding affinity of progestins (1978) J Toxicol Environ Health, 4, pp. 205-227
• Funder, J.W., Pearce, P., Smith, R., Smith, A.I., Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated (1988) Science (Wash DC), 242, pp. 583-585
• Galigniana, M.D., Stability study on renal type I mineralocorticoid receptor (1996) Life Sci, 59, pp. 511-521
• Galigniana, M.D., Native rat kidney mineralocorticoid receptor is a phospho-protein whose transformation to a DNA-binding form is induced by phosphatases (1998) Biochem J, 333, pp. 555-563
• Galigniana, M.D., Housley, P.R., Defranco, D.B., Pratt, W.B., Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton (1999) J Biol Chem, 274, pp. 16222-16227
• Galigniana, M.D., Piwien-Pilipuk, G., Comparative inhibition by hard and soft metal ions of steroid-binding capacity of renal mineralocorticoid receptor cross-linked to the 90-kDa heat-shock protein heterocomplex (1999) Biochem J, 341, pp. 585-592
• Galigniana, M.D., Vicent, G.P., Lantos, C.P., Burton, G., 11,19-Oxidoprogesterone: A potent sodium retaining steroid binding to an alternative site in kidney type I receptor (1994) Eur J Endocrinol, 130 (SUPPL. 2), p. 260
• Galigniana, M.D., Vicent, G.P., Burton, G., Lantos, C.P., Features of the shuttle pair 11β-hydroxyprogesterone/11-ketoprogesterone (1997) Steroids, 62, pp. 358-364
• Galigniana, M.D., Scruggs, J.L., Herrington, J., Welsh, M.J., Carter-Su, C., Housley, P.R., Pratt, W.B., Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton (1998) Mol Endocrinol, 12, pp. 1903-1913
• Jones, T.R., Bell, P.A., Glucocorticoid-receptor interactions: Studies of the negative cooperativity induced by steroid interactions with a secondary, hydrophobic, binding site (1980) Biochem J, 188, pp. 237-245
• Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Chambon, P., Activation of estrogen receptor through phosphorylation by mitogen-activated protein kinase (1995) Science (Wash DC), 270, pp. 1491-1494
• Krozowski, Z.S., Funder, J.W., Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity (1983) Proc Natl Acad Sci USA, 80, pp. 6056-6060
• Lantos, C.P., Burton, G., Roldán, A., Damasco, M.C., Aragonés, A., Structure-activity relationship in certain glucocorticoids and mineralocorticoids (1981) Physiopathology of Endocrine Diseases and Mechanisms of Hormone Action, pp. 477-494. , Soto RJ, de Nicola A and Blaquier J, eds Alan R. Liss, New York
• Lilley, K.S., Engel, P.C., The essential active-site lysines of clostridial glutamate dehydrogenase: A study with pyridoxal-5′-phosphate (1992) Eur J Biochem, 207, pp. 533-540
• McDonnell, D., Clemm, D., Herman, T., Goldman, M.E., Pike, J.W., Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens (1995) Mol Endocrinol, 9, pp. 659-669
• Migliaccio, A., Di Domenico, M., Castoria, G., De Falco, A., Bontempo, P., Nola, E., Auricchio, F., Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells (1996) EMBO J, 15, pp. 1292-1300
• Morris, D., The metabolism and mechanism of action of aldosterone (1981) Endocr Rev, 2, pp. 234-247
• Morris, D.J., Tsai, R., De Conti, G., Regulation of plasma levels of aldosterone and its metabolites during the latent period of aldosterone (1976) J Steroid Biochem, 7, pp. 971-978
• Nemere, I., Zhou, L., Norman, A., Nontranscriptional effects of steroid hormones (1993) Receptor, 3, pp. 277-291
• Piwien-Pilipuk, G., Galigniana, M.D., Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor (1998) Mol Cell Endocrinol, 144, pp. 119-130
• Piwien-Pilipuk, G., Galigniana, M.D., Oxidative stress induced by L-buthionine-(S,R)-sulfoximine, a selective inhibitor of the glutathione metabolism, inhibits the mouse kidney mineralocorticoid receptor function (2000) Biochim Biophys Acta, 1495, pp. 263-280
• Pratt, W.B., Toft, D.O., Steroid receptor interactions with heat shock protein and immunophilin chaperones (1997) Endocr Rev, 18, pp. 306-360
• Renaud, J.P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., Moras, D., Crystal structure of the RAR-γ ligand-binding domain bound to all trans retinoic acid (1995) Nature (Lond), 378, pp. 681-689
• Scherrer, L.C., Dalman, F.C., Massa, E., Meshinchi, S., Pratt, W.B., Structural and functional reconstitution of the glucocorticoid receptor-hsp90 heterocomplex (1990) J Biol Chem, 267, pp. 21397-21400
• Souque, A., Fagart, J., Couette, B., Rafestin-Oblin, M.E., Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor (1996) J Steroid Biochem Mol Biol, 67, pp. 315-321
• Svec, F., Teubner, V., Tate, D., Location of the second steroid-binding site on the glucocorticoid receptor (1989) Endocrinology, 125, pp. 3103-3108
• Teutsch, G., Nique, F., Lemoine, G., Bouchoux, F., Cérède, G.D., Philibert, D., General structure-activity correlations of antihormones (1995) Ann N Y Acad Sci, 761, pp. 5-28
• Vegeto, E., Allan, G.F., Schrader, W.T., Tsai, M.J., McDonnell, D., O'Malley, B.W., The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor (1992) Cell, 69, pp. 703-713
• Vicent, G.P., Burton, G., Ghini, A., Lantos, C.P., Galigniana, M.D., Influence of calf serum on glucocorticoid-responses of certain progesterone derivatives (1998) J Steroid Biochem Mol Biol, 66, pp. 211-217
• Vicent, G.P., Monteserín, M.C., Veleiro, A.S., Burton, G., Lantos, C.P., Galigniana, M.D., 21-Hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat (1997) Mol Pharmacol, 52, pp. 749-753
• Vicent, G.P., Pecci, A., Ghini, A., Piwien-Pilipuk, G., Burton, G., Lantos, C.P., Galigniana, M.D., The glucocorticoid properties of the synthetic steroid pregna-1,4-diene-11β-ol-3,20-dione (ΔHOP) are not entirely correlated with the steroid binding to the glucocorticoid receptor (1999) Mol Cell Endocrinol, 149, pp. 207-219
• Waynforth, H.B., (1980) Experimental and Surgical Technique in the Rat, , Academic Press, London
• Williams, S.P., Sigler, P.B., Atomic structure of progesterone complexed with its receptor (1998) Nature (Lond), 393, pp. 392-396
• Yamakawa, Y., Ezumi, K., Shiro, M., Nakai, H., Kamata, S., Matsui, T., Haga, N., Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor (1986) Mol Pharmacol, 30, pp. 585-589

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------